A Study of the Effect of Multiple Doses of Rifampin on the Single Dose Pharmacokinetics of RO5424802
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
This single center, open-label, 3-period, fixed-sequence study will evaluate the effect of
multiple oral doses of rifampin on the pharmacokinetics of a single oral dose of RO5424802 in
healthy volunteers. Subjects will receive a single dose of RO5424802 on Days 1 and 17 and
rifampin daily from Days 8 to Day 20.